Home
About Optovent AB
Products and pipeline
Technology
Primary applications
Press
Contact
About Optovent AB

Optovent AB is a development company with focus on platform technologies for drug delivery. The primary application is within cancer therapy and based on the RHCC proprietary technology.

Management

  Trine Vikinge
  Andreas Bunge

Optovent AB is a subsidiary of Accelerator Nordic AB.
Optovent AB  Box 1224  SE-581 12  Linköping  Sweden  Telephone: +46 8 663 5700